Ng IO - Search Results

1

Clinicopathologic and prognostic significance of the histologic activity of noncancerous liver tissue in hepatitis B virus-associated hepatocellular carcinoma.

Ng IO, Poon RT, Shek TW, Fan ST. Ng IO, et al. Am J Clin Pathol. 2002 Mar;117(3):411-8. doi: 10.1309/4231-RCVB-WK8X-R1JK. Am J Clin Pathol. 2002. PMID: 11892725

2

Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.

Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST, So S. Cheung ST, et al. Among authors: ng io. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):551-6. Clin Cancer Res. 2005. PMID: 15701840

3

Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.

Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT; International Cooperative Study Group on Hepatocellular Carcinoma. Ng KK, et al. Among authors: ng io. Ann Surg Oncol. 2005 May;12(5):364-73. doi: 10.1245/ASO.2005.06.004. Epub 2005 Mar 31. Ann Surg Oncol. 2005. PMID: 15915370

4

FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.

Lee TK, Man K, Ho JW, Wang XH, Poon RT, Xu Y, Ng KT, Chu AC, Sun CK, Ng IO, Sun HC, Tang ZY, Xu R, Fan ST. Lee TK, et al. Among authors: ng io, ng kt. Clin Cancer Res. 2005 Dec 1;11(23):8458-66. doi: 10.1158/1078-0432.CCR-05-0447. Clin Cancer Res. 2005. PMID: 16322309

5

Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.

Lee TK, Man K, Poon RT, Lo CM, Yuen AP, Ng IO, Ng KT, Leonard W, Fan ST. Lee TK, et al. Among authors: ng io, ng kt. Cancer Res. 2006 Oct 15;66(20):9948-56. doi: 10.1158/0008-5472.CAN-06-1092. Cancer Res. 2006. PMID: 17047057

6

Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening.

Lam CM, Chan AO, Ho P, Ng IO, Lo CM, Liu CL, Poon RT, Fan ST. Lam CM, et al. Among authors: ng io. Aliment Pharmacol Ther. 2004 Apr 1;19(7):771-7. doi: 10.1111/j.1365-2036.2004.01912.x. Aliment Pharmacol Ther. 2004. PMID: 15043518 Free article.

7

Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.

Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST. Poon RT, et al. Among authors: ng io. Br J Surg. 2004 Oct;91(10):1354-60. doi: 10.1002/bjs.4594. Br J Surg. 2004. PMID: 15376182

8

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.

Lo CM, Liu CL, Chan SC, Lam CM, Poon RT, Ng IO, Fan ST, Wong J. Lo CM, et al. Among authors: ng io. Ann Surg. 2007 Jun;245(6):831-42. doi: 10.1097/01.sla.0000245829.00977.45. Ann Surg. 2007. PMID: 17522506 Free PMC article. Clinical Trial.

9

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.

Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, Lowe SW, Poon RT, Luk JM. Xu MZ, et al. Among authors: ng io. Cancer. 2009 Oct 1;115(19):4576-85. doi: 10.1002/cncr.24495. Cancer. 2009. PMID: 19551889 Free PMC article.

10

Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.

Wong CM, Lee JM, Lau TC, Fan ST, Ng IO. Wong CM, et al. Among authors: ng io. Clin Cancer Res. 2002 Jul;8(7):2266-72. Clin Cancer Res. 2002. PMID: 12114430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page